Literature DB >> 6307803

Quantitative determination of non-sulfated bile acids in the serum of patients with hepatobiliary diseases by mass fragmentography.

H Takikawa, T Beppu, Y Seyama, T Wada.   

Abstract

Individual non-sulfated bile acids in the serum of 65 patients with hepatobiliary diseases were quantitated by mass fragmentography. Serum with deuterium labeled deoxycholic acid as an internal standard was hydrolyzed with strong alkali, extracted with ether after acidification under cooling, and quantitated by mass fragmentography as the hexafluoroisopropyl-trifluoracetyl derivatives. In obstructive jaundice, the ratio of cholic to chenodeoxycholic acid was significantly higher than others. Cholic or chenodeoxycholic acid levels were correlated with total bilirubin levels in obstructive jaundice and acute hepatitis. Lithocholic acid value was independent of the degree of liver injury. Total bile acid value was helpful in estimating the extent of liver cell injury and cholestasis, and these two pathological conditions can be distinguished to some extent by cholic to chenodeoxychoic acid ratio.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6307803     DOI: 10.1007/bf02774967

Source DB:  PubMed          Journal:  Gastroenterol Jpn        ISSN: 0435-1339


  18 in total

1.  MEASUREMENT OF HUMAN SERUM BILE ACIDS BY GAS-LIQUID CHROMATOGRAPHY.

Authors:  D H SANDBERG; J SJOEVALL; K SJOEVALL; D A TURNER
Journal:  J Lipid Res       Date:  1965-04       Impact factor: 5.922

2.  Serum-bile-acid levels in liver disease.

Authors:  E C OSBORN; I D WOOTTON; L da SILVA; S SHERLOCK
Journal:  Lancet       Date:  1959-12-12       Impact factor: 79.321

3.  Conjugated and unconjugated serum bile acid levels n patients with hepatobiliary diseases.

Authors:  I Makino; S Nakagawa; K Mashimo
Journal:  Gastroenterology       Date:  1969-06       Impact factor: 22.682

4.  An improved gas-chromatographic method for the determination of sulfated and unsulfated bile acids in serum.

Authors:  A Cantafora; M Angelico; A F Attili; L Ercoli; L Capocaccia
Journal:  Clin Chim Acta       Date:  1979-08-01       Impact factor: 3.786

5.  Sulphated and unsulphated bile acids in serum, bile, and urine of patients with cholestasis.

Authors:  G P van Berge Henegouwen; K H Brandt; H Eyssen; G Parmentier
Journal:  Gut       Date:  1976-11       Impact factor: 23.059

6.  Serum bile acids in primary biliary cirrhosis.

Authors:  J R Bloomer; R M Allen; G Klatskin
Journal:  Arch Intern Med       Date:  1976-01

7.  Quantitative determination of bile acid glucuronides in serum by mass fragmentography.

Authors:  H Takikawa; H Otsuka; T Beppu; Y Seyama; T Yamakawa
Journal:  J Biochem       Date:  1982-10       Impact factor: 3.387

8.  Quantitative determination of individual non-sulfated bile acids and sulfated lithocholic acid in serum by mass fragmentography.

Authors:  T Beppu; Y Seyama; T Kasama; T Yamakawa
Journal:  J Biochem       Date:  1981-06       Impact factor: 3.387

9.  Serum bile acid profiles in cerebrotendinous xanthomatosis.

Authors:  T Beppu; Y Seyama; T Kasama; S Serizawa; T Yamakawa
Journal:  Clin Chim Acta       Date:  1982-02-05       Impact factor: 3.786

10.  Serum bile acids in liver disease.

Authors:  G Neale; B Lewis; V Weaver; D Panveliwalla
Journal:  Gut       Date:  1971-02       Impact factor: 23.059

View more
  4 in total

1.  Bile acid profile and decrement rate of serum total bilirubin after biliary drainage.

Authors:  T Kosuge; T Beppu; S Iwasaki; T Itoh; Y Idezuki
Journal:  Gastroenterol Jpn       Date:  1990-12

2.  Urinary concentrations of bile acid glucuronides and sulfates in hepatobiliary diseases.

Authors:  H Takikawa; T Beppu; Y Seyama
Journal:  Gastroenterol Jpn       Date:  1984-04

3.  Glucuronidated and sulfated bile acids in serum of patients with acute hepatitis.

Authors:  H Takikawa; T Beppu; Y Seyama; T Sugimoto
Journal:  Dig Dis Sci       Date:  1986-05       Impact factor: 3.199

4.  Profiles of bile acids and their glucuronide and sulphate conjugates in the serum, urine and bile from patients undergoing bile drainage.

Authors:  H Takikawa; T Beppu; Y Seyama
Journal:  Gut       Date:  1985-01       Impact factor: 23.059

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.